HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Narong Khuntikeo Selected Research

Digestive System Diseases

1/2020Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort.
1/2019Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG.
1/2018Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
1/2017Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma.
8/2012Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Narong Khuntikeo Research Topics

Disease

72Cholangiocarcinoma
01/2022 - 01/2005
45Neoplasms (Cancer)
08/2021 - 06/2007
15Opisthorchiasis
06/2022 - 08/2012
14Infections
10/2020 - 03/2008
9Inflammation (Inflammations)
01/2020 - 03/2012
9Fibrosis (Cirrhosis)
01/2019 - 08/2012
7Carcinogenesis
08/2017 - 03/2008
6Neoplasm Metastasis (Metastasis)
03/2021 - 03/2014
5Digestive System Diseases
01/2020 - 08/2012
4Hepatocellular Carcinoma (Hepatoma)
02/2020 - 07/2009
2Body Weight (Weight, Body)
10/2021 - 08/2018
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2021 - 01/2012
2Reinfection
10/2020 - 01/2017
2Lymphatic Metastasis
02/2020 - 08/2014
2Parasitic Diseases (Parasitic Disease)
08/2017 - 03/2008
2Cholangitis
01/2017 - 01/2014
1Hyperbilirubinemia
12/2020
1Liver Failure
12/2020
1Liver Diseases (Liver Disease)
01/2020
1Pathologic Constriction (Stenosis)
01/2020
1Bile Duct Neoplasms (Bile Duct Cancer)
12/2018

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
04/2021 - 04/2012
16Biomarkers (Surrogate Marker)IBA
08/2021 - 01/2005
9EnzymesIBA
03/2021 - 09/2008
8Praziquantel (Biltricide)FDA Link
10/2020 - 08/2012
6Pharmaceutical PreparationsIBA
10/2021 - 04/2018
5AntigensIBA
10/2020 - 01/2014
58-Hydroxy-2'-DeoxyguanosineIBA
01/2019 - 03/2008
4GemcitabineFDA Link
01/2022 - 01/2018
4ImmunosorbentsIBA
03/2021 - 01/2017
4Immunoglobulin G (IgG)IBA
01/2021 - 01/2013
3Bile Acids and Salts (Bile Acids)IBA
01/2020 - 01/2012
3CarcinogensIBA
03/2019 - 12/2016
3Cadherins (E-Cadherin)IBA
11/2016 - 12/2012
3Dimethylnitrosamine (Nitrosodimethylamine)IBA
03/2016 - 04/2013
3Indicators and Reagents (Reagents)IBA
12/2014 - 07/2006
3Messenger RNA (mRNA)IBA
06/2014 - 08/2012
3DNA (Deoxyribonucleic Acid)IBA
03/2012 - 07/2006
2Formaldehyde (Formol)FDA Link
06/2022 - 10/2020
2ethyl acetateIBA
06/2022 - 10/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2021
26-propylchromone-2-carboxylic acid (PCCA)IBA
05/2021 - 12/2015
2Interleukin-6 (Interleukin 6)IBA
04/2021 - 06/2017
2Calcium-Binding ProteinsIBA
03/2021 - 04/2018
2AntioxidantsIBA
01/2021 - 02/2017
2LipidsIBA
01/2021 - 01/2020
2Transferrin (beta 2 Transferrin)IBA
01/2019 - 04/2012
2MicroRNAs (MicroRNA)IBA
08/2017 - 12/2014
2CytokinesIBA
06/2017 - 02/2017
2Fluorouracil (Carac)FDA LinkGeneric
08/2012 - 01/2012
2Eosine Yellowish-(YS) (Eosin)IBA
08/2012 - 03/2012
2Hematoxylin (Haematoxylon)IBA
08/2012 - 03/2012
1UridineIBA
10/2021
1NucleotidesIBA
10/2021
1XenobioticsIBA
10/2021
1PseudouridineIBA
10/2021
1Biological ProductsIBA
10/2021
17-methylguanineIBA
10/2021
1Cell-Free Nucleic AcidsIBA
05/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2021
1Angiopoietin-2IBA
03/2021
1Mucin 5ACIBA
03/2021
1Sulfasalazine (Azulfidine)FDA LinkGeneric
03/2021
1Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
01/2021
1NestinIBA
01/2021
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
01/2021
16- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA
01/2021
1Acetyl-CoA CarboxylaseIBA
01/2021
1BilirubinIBA
12/2020
1human ERBB2 proteinIBA
02/2020
1beta CateninIBA
02/2020
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
02/2020
1ErbB Receptors (EGF Receptor)IBA
02/2020
1ErythropoietinFDA Link
02/2020
1Protein Kinases (Protein Kinase)IBA
02/2020
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2020
1Vascular Endothelial Growth Factor CIBA
02/2020
1Aspartic Acid (Aspartate)FDA Link
01/2020
1Amino AcidsFDA Link
01/2020
1Phenylalanine (L-Phenylalanine)FDA Link
01/2020
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1SteroidsIBA
01/2020
1Polysaccharides (Glycans)IBA
01/2019
1Blood Proteins (Serum Proteins)IBA
01/2019
17,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
01/2019
1Estrogens (Estrogen)FDA Link
12/2018
1Estrogen ReceptorsIBA
12/2018
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
08/2018
1NVP-BKM120IBA
08/2018
1CarbohydratesIBA
04/2018

Therapy/Procedure

5Drug Therapy (Chemotherapy)
04/2021 - 07/2016
5Therapeutics
01/2018 - 06/2007
3Adjuvant Chemotherapy
01/2019 - 01/2012
2Aftercare (After-Treatment)
08/2021 - 02/2020
2Hepatectomy
01/2021 - 12/2020
2Oral Administration
01/2020 - 08/2018
1Blood Transfusion (Blood Transfusions)
01/2021
1Catheters
01/2020
1Endoscopes
01/2020